Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular Carcinoma.
Journal Information
Journal Title: J Hepatocell Carcinoma
Detailed journal information not available.
Publication Details
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Disclosure The authors declare that they have no competing interests in this work."
Funding Disclosure
Evidence found in paper:
"This work was supported by the National Natural Science Foundation of China (81971717), Key Projects of CSCO-Bayer Cancer Research Fund (Y-bayer202002-0091), and Beijing Hospital authority of Hospitals’ Ascent Plan (DFL20220903)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025